ネクセラファーマの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2022/03/10 | 1,387 | 1,398 | 1,369 | 1,391 | +49 | +3.7% | 728,100 |
| 2022/03/09 | 1,350 | 1,360 | 1,301 | 1,342 | +7 | +0.5% | 978,500 |
| 2022/03/08 | 1,311 | 1,361 | 1,300 | 1,335 | +15 | +1.1% | 1,338,600 |
| 2022/03/07 | 1,325 | 1,355 | 1,301 | 1,320 | -44 | -3.2% | 1,154,200 |
| 2022/03/04 | 1,430 | 1,438 | 1,342 | 1,364 | -69 | -4.8% | 1,412,700 |
| 2022/03/03 | 1,460 | 1,473 | 1,412 | 1,433 | -7 | -0.5% | 983,000 |
| 2022/03/02 | 1,427 | 1,469 | 1,416 | 1,440 | +9 | +0.6% | 1,406,000 |
| 2022/03/01 | 1,414 | 1,439 | 1,384 | 1,431 | +12 | +0.8% | 1,516,500 |
| 2022/02/28 | 1,399 | 1,433 | 1,380 | 1,419 | +5 | +0.4% | 958,600 |
| 2022/02/25 | 1,375 | 1,421 | 1,355 | 1,414 | +81 | +6.1% | 1,497,600 |
| 2022/02/24 | 1,407 | 1,414 | 1,311 | 1,333 | -77 | -5.5% | 2,403,900 |
| 2022/02/22 | 1,381 | 1,451 | 1,380 | 1,410 | +5 | +0.4% | 1,300,500 |
| 2022/02/21 | 1,420 | 1,424 | 1,377 | 1,405 | -50 | -3.4% | 1,351,800 |
| 2022/02/18 | 1,409 | 1,461 | 1,403 | 1,455 | +16 | +1.1% | 1,148,100 |
| 2022/02/17 | 1,488 | 1,493 | 1,424 | 1,439 | -38 | -2.6% | 1,382,400 |
| 2022/02/16 | 1,510 | 1,512 | 1,466 | 1,477 | -3 | -0.2% | 1,155,300 |
| 2022/02/15 | 1,470 | 1,519 | 1,464 | 1,480 | ±0 | ±0% | 1,049,100 |
| 2022/02/14 | 1,432 | 1,480 | 1,375 | 1,480 | -52 | -3.4% | 1,868,200 |
| 2022/02/10 | 1,515 | 1,539 | 1,505 | 1,532 | +40 | +2.7% | 1,124,900 |
| 2022/02/09 | 1,479 | 1,500 | 1,455 | 1,492 | +32 | +2.2% | 881,500 |
| 2022/02/08 | 1,470 | 1,493 | 1,449 | 1,460 | -2 | -0.1% | 787,600 |
| 2022/02/07 | 1,498 | 1,520 | 1,456 | 1,462 | -38 | -2.5% | 1,018,600 |
| 2022/02/04 | 1,515 | 1,524 | 1,478 | 1,500 | -23 | -1.5% | 1,207,300 |
| 2022/02/03 | 1,525 | 1,548 | 1,502 | 1,523 | -42 | -2.7% | 1,108,400 |
| 2022/02/02 | 1,528 | 1,575 | 1,528 | 1,565 | +64 | +4.3% | 1,030,800 |
| 2022/02/01 | 1,531 | 1,556 | 1,482 | 1,501 | -16 | -1.1% | 1,645,800 |
| 2022/01/31 | 1,493 | 1,525 | 1,464 | 1,517 | +47 | +3.2% | 1,671,200 |
| 2022/01/28 | 1,510 | 1,529 | 1,437 | 1,470 | -18 | -1.2% | 1,638,600 |
| 2022/01/27 | 1,517 | 1,555 | 1,464 | 1,488 | -30 | -2% | 1,866,400 |
| 2022/01/26 | 1,505 | 1,539 | 1,480 | 1,518 | +17 | +1.1% | 1,338,400 |
| 2022/01/25 | 1,563 | 1,575 | 1,495 | 1,501 | -63 | -4% | 1,572,800 |
| 2022/01/24 | 1,549 | 1,579 | 1,523 | 1,564 | +12 | +0.8% | 1,263,400 |
| 2022/01/21 | 1,580 | 1,585 | 1,507 | 1,552 | -70 | -4.3% | 2,127,000 |
| 2022/01/20 | 1,592 | 1,630 | 1,570 | 1,622 | +34 | +2.1% | 1,531,700 |
| 2022/01/19 | 1,608 | 1,632 | 1,579 | 1,588 | -44 | -2.7% | 1,429,600 |
| 2022/01/18 | 1,654 | 1,680 | 1,618 | 1,632 | -33 | -2% | 1,488,400 |
| 2022/01/17 | 1,700 | 1,700 | 1,653 | 1,665 | -47 | -2.7% | 1,086,400 |
| 2022/01/14 | 1,690 | 1,720 | 1,650 | 1,712 | -15 | -0.9% | 1,504,100 |
| 2022/01/13 | 1,754 | 1,755 | 1,712 | 1,727 | -63 | -3.5% | 1,306,400 |
| 2022/01/12 | 1,801 | 1,804 | 1,761 | 1,790 | +20 | +1.1% | 1,215,500 |
| 2022/01/11 | 1,727 | 1,777 | 1,709 | 1,770 | +46 | +2.7% | 1,840,200 |
| 2022/01/07 | 1,793 | 1,800 | 1,681 | 1,724 | -13 | -0.7% | 4,315,200 |
| 2022/01/06 | 1,805 | 1,846 | 1,730 | 1,737 | -93 | -5.1% | 2,491,200 |
| 2022/01/05 | 1,895 | 1,900 | 1,809 | 1,830 | -96 | -5% | 1,596,500 |
| 2022/01/04 | 1,921 | 1,928 | 1,899 | 1,926 | +22 | +1.2% | 788,600 |
| 2021/12/30 | 1,940 | 1,954 | 1,898 | 1,904 | -37 | -1.9% | 926,900 |
| 2021/12/29 | 1,928 | 1,958 | 1,918 | 1,941 | +13 | +0.7% | 599,000 |
| 2021/12/28 | 1,956 | 1,959 | 1,920 | 1,928 | -21 | -1.1% | 890,100 |
| 2021/12/27 | 1,991 | 1,994 | 1,904 | 1,949 | -64 | -3.2% | 1,719,600 |
| 2021/12/24 | 2,028 | 2,061 | 1,989 | 2,013 | -12 | -0.6% | 1,453,300 |
801～
850
件表示中 / 5112件
類似銘柄と比較する
現在ご覧いただいている「ネクセラファーマ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| ネクセラファーマ | 90,000円 | +20.3% | - | 0.00% | 159.57倍 | 1.19倍 |
|
創薬ベンチャー老舗。買収で成長。英国の創薬事業に日本が柱の後期治験・製造販売事業加わる |
| ハートシード | 366,500円 | +174.2% | - | 0.00% | - | 11.00倍 |
|
慶応大学発ベンチャー。ｉＰＳ細胞を使い独自の心筋再生用心筋球で重症心不全治療を目指す |
| 栄研化 | 212,900円 | +4.1% | -3.1% | 2.72% | 18.54倍 | 1.62倍 |
|
臨床検査薬大手。便潜血検査試薬（ＦＩＴ）はシェア７割。尿検査（ウロ）、遺伝子検査も育成 |
| ＪＣＲファーマ | 54,800円 | +14.3% | - | 3.65% | 22.26倍 | 1.42倍 |
|
ヒト成長ホルモン製剤が主力、バイオ後続品も成長。希少疾病のバイオ新薬開発にも取り組む |
| あすかＨＤ | 232,900円 | +16.9% | +33.2% | 2.36% | 12.70倍 | 1.01倍 |
|
武田と親密。婦人科領域に強い。先発品比率引き上げに注力。２１年春にあすか製薬が持株会社化 |
市場注目の銘柄
チャート関連のコラム
